Variable | n/Valid Cases (%) |
---|---|
Sex and Age | |
Female, n/N (%) | 237/566 (41.9) |
Age years, median (IQR) | 62 (45;74) |
Charlson Comorbidity Index | |
0, n/N (%) | 161/566 (28.4) |
1–2, n/N (%) | 138/566 (24.4) |
3–4, n/N (%) | 159/566 (28.1) |
≥ 5, n/N (%) | 108/566 (19.1) |
Antiplatelet/−coagulant treatment | |
Yes, n/N (%) | 144/556 (25.9) |
- Acetylsalicylic acid, n/N (%) | 65/144 (45.1) |
- ADP-receptor antagonist, n/N (%) | 32/144 (22.2) |
- Vitamin K antagonist, n/N (%) | 18/144 (12.5) |
- NOAC, n/N (%) | 32/144 (22.2) |
No, n/N (%) | 412/556 (74.1) |
Trauma Mechanism | |
Traffic, n/N (%) | 143/557 (25.6) |
Fall < 2 m, n/N (%) | 350/557 (62.8) |
Fall > 2 m, n/N (%) | 17/557 (3.1) |
Violence, n/N (%) | 14/557 (2.5) |
Other, n/N (%) | 33/557 (5.9) |
Alcohol/drugs prior to trauma | |
Suspected, n/N (%) | 161/521 (30.9) |
Not suspected, n/N (%) | 360/521 (69.1) |
GCS at inclusion | |
GCS 15 | 453/566 (80.0) |
GCS 14 | 113/566 (20.0) |